Immunotherapy duo aims to boost lung cancer cure rates before surgery
NCT ID NCT05742607
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This phase 2 trial is testing whether adding two immunotherapy drugs, IPH5201 and durvalumab, to standard chemotherapy before and after surgery can improve outcomes for people with early-stage (stage II to III) non-small cell lung cancer. The study includes two groups: one receiving the combination both before and after surgery, and another receiving it only before surgery. The main goals are to see how many patients have no cancer cells left after treatment and to monitor side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
IPH5201 and durvalumab (immunotherapy drugs) plus standard chemotherapy
What this could lead to
If successful, this combination could improve the chance of eliminating lung cancer before surgery and reduce the risk of it returning afterward.
What could go wrong
This is a mid-stage trial with only 70 participants, so results may not apply to all patients. Immunotherapy can cause serious immune-related side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL-CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Angers University Hospital Center
TERMINATEDAngers, 49333, France
-
CHU de Limoges
RECRUITINGLimoges, 87042, France
Contact
-
Charles Nicolle Hospital
TERMINATEDRouen, 76031, France
-
Eugenia and Janusz Zeyland Wielkopolskie Centre of Pulmonology and Thoracic Surgery
TERMINATEDPoznan, 60-569, Poland
-
Gustave Roussy
RECRUITINGVillejuif, 94805, France
Contact
-
H. Lee Moffitt Cancer Center & Research Institute
TERMINATEDTampa, Florida, 33612, United States
-
Henry Dunant Hospital Center
WITHDRAWNAthens, 11526, Greece
-
Hospital Calmette
NOT_YET_RECRUITINGLille, 59037, France
Contact
-
Jasz-Nagykun-Szolnok County Hetenyi Geza Hospital-Clinic, Department of Oncology
RECRUITINGSzolnok, H-5000, Hungary
Contact
-
John Paul II Specialist Hospital in Krakow
TERMINATEDKrąków, 31-202, Poland
-
Koranyi National Institute of Pulmonology, 14th Department of Pulmonology
RECRUITINGBudapest, H-1121, Hungary
Contact
-
Leon Berard Center
RECRUITINGLyon, 69373, France
Contact
-
Mandziuk Slawomir - Specialist Medical Practice
TERMINATEDLublin, 20-093, Poland
-
Marseille University Hospital Center - North Hospital
RECRUITINGMarseille, 13015, France
Contact
-
Military Institute of Medicine - National Research Institute
TERMINATEDWarsaw, 04-141, Poland
-
Millennium Research & Clinical Development
TERMINATEDHouston, Texas, 77090, United States
-
Northwell Health Cancer Institute / Center for Novel Cancer Therapeutics
WITHDRAWNLake Success, New York, 11042, United States
-
Petz Aladar University Teaching Hospital, Department of Pulmonology
TERMINATEDGyőr, 9024, Hungary
-
Pulmonology Institute Torokbalint
NOT_YET_RECRUITINGTörökbálint, H-2045, Hungary
Contact
-
Rennes University Hospital Center - Hospital Pontchaillou
RECRUITINGRennes, 35033, France
Contact
-
Specialist Hospital in Prabuty Sp. z o.o. (LLC)
RECRUITINGPrabuty, 82-550, Poland
Contact
-
St. Anthony's Hospital - BayCare Health System
TERMINATEDSt. Petersburg, Florida, 33705, United States
-
UW Carbone Cancer Center - Cancer Connect
TERMINATEDMadison, Wisconsin, 53792, United States
-
University General Hospital "Attikon"
RECRUITINGAthens, 12462, Greece
Contact
-
University General Hospital of Ioannina
TERMINATEDIoannina, 45500, Greece
-
University General Hospital of Patras
TERMINATEDPátrai, 26504, Greece
-
University Hospital Center Caen
TERMINATEDCaen, 14033, France
-
University Teaching Hospital in Bialystok, 2nd Department of Lung Diseases and Tuberculosis
RECRUITINGBialystok, 15-540, Poland
Contact
-
University of Chicago Medical Center
WITHDRAWNChicago, Illinois, 60637, United States
-
Veszprem County Pulmonology Institute
TERMINATEDFarkasgyepű, 8582, Hungary